A Ligated Intestinal Loop Model in Anesthetized Specific Pathogen Free Chickens to Study Clostridium Perfringens Virulence
October 11th, 2018
9K views
Here we present a protocol to surgically create 'intestinal ligated loops' in chicken small intestines. This procedure allows for the comparison of multiple Clostridium perfringens strains' virulence in situ in a single host. This method markedly decreases the number of chickens usually necessary for similar in vivo experiments.
Overview
This article presents a surgical protocol for creating 'intestinal ligated loops' in chicken small intestines, enabling the comparison of Clostridium perfringens strains' virulence in situ. This method significantly reduces the number of chickens required for in vivo experiments.
Key Study Components
Area of Science
- Microbiology
- Veterinary Science
- Pathogen Virulence
Background
- Necrotic Enteritis is a significant disease in poultry caused by Clostridium perfringens.
- Understanding virulence factors is crucial for disease management.
- Traditional methods often require large numbers of animals for testing.
- This new method aims to address ethical concerns regarding animal use.
Purpose of Study
- To compare the virulence of different Clostridium perfringens strains.
- To reduce the number of chickens needed for such experiments.
- To provide insights applicable to other intestinal pathogens.
Methods Used
- Surgical creation of intestinal ligated loops in chickens.
- Monitoring of vital signs during the procedure.
- Application of the method to assess virulence in situ.
- Training required for surgical techniques like suturing.
Main Results
- The method allows for effective comparison of virulence in a single host.
- It can be adapted for studying other pathogens like Clostridium difficile and Salmonella enterica.
- Significant reduction in the number of animals used for research.
- Potential to enhance understanding of pathogen behavior in vivo.
Conclusions
- The surgical protocol is a valuable tool for necrotic enteritis research.
- It addresses ethical concerns by minimizing animal use.
- Further studies can expand its application to other intestinal diseases.
Frequently Asked Questions
What is the main advantage of this surgical method?
The main advantage is the significant reduction in the number of chickens required for virulence studies.
Can this method be applied to other pathogens?
Yes, it can also be applied to pathogens like Clostridium difficile and Salmonella enterica.
What training is required for this procedure?
Specific training in surgical techniques, including suturing, is necessary before performing the procedure.
How does this method contribute to animal welfare?
By reducing the number of animals needed for experiments, it addresses ethical concerns regarding animal use in research.
What type of chickens are used in this study?
Specific pathogen-free Leghorn chickens are used for the experiments.
What are the vital measurements monitored during the procedure?
Vital signs such as heart rate and respiratory rate are monitored during the surgical procedure.
Executive Industry Relevance
The ligated intestinal loop model in anesthetized chickens enables direct, quantitative comparison of Clostridium perfringens strain virulence with reduced animal use. This approach addresses ethical imperatives while supporting robust, statistically significant outputs for pathogen characterization. The model enhances predictive confidence in early-stage target validation and mechanistic de-risking for enteric disease research portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of pathogen virulence mechanisms in a controlled in vivo system.
- Supports functional target validation by isolating strain-specific effects on intestinal tissue.
- Facilitates mechanistic de-risking by distinguishing procedural artifacts from true pathogenic lesions.
- Reduces animal numbers required for statistically powered comparisons, aligning with ethical mandates.
Screening & Assay Development
- Prepares standardized, reproducible biological systems for downstream pathogen or therapeutic screening.
- Enables quantitative measurement of dependent variables such as histopathological damage and bacterial recovery.
- Supports assay scalability by allowing multiple strains or controls within a single host.
- Improves screening reliability by minimizing confounding predisposing factors.
Translational & Preclinical Research
- Provides a disease-relevant model for translational studies of enteric pathogen-host interactions.
- Ensures continuity from discovery through preclinical validation by enabling direct tissue and pathogen sampling.
- Supports risk-adjusted advancement decisions by clarifying strain-specific pathogenicity profiles.
Pipeline & Workflow Integration
This model integrates at the interface of early discovery and preclinical validation, supporting both mechanistic studies and comparative virulence screening.
- Discovery Biology: Facilitates hypothesis testing on strain virulence and host response in a controlled setting.
- Screening: Delivers reproducible, quantitative outputs for cross-strain and control comparisons.
- Analytics: Enables statistical analysis of histopathology and bacterial recovery across multiple conditions.
- Translational Research: Aligns with disease-relevant endpoints for enteric pathogen research.
- Enterprise Reuse: Adaptable for other intestinal pathogens, supporting broader R&D utility.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in pathogen studies.
- Operational Value: Standardizes procedures, enhances reproducibility, and minimizes animal use.
- Strategic Value: Improves go/no-go decisions and capital efficiency by clarifying virulence profiles early.
- Portfolio Impact: Enables risk-adjusted prioritization of strains or interventions for further development.
Implementation Considerations
- Requires specialized surgical expertise and training in avian procedures.
- Demands access to anesthesia, monitoring, and histopathological analysis infrastructure.
- Necessitates rigorous cross-team standardization to ensure reproducibility and valid comparisons.
- Adaptable to other intestinal pathogens with appropriate protocol modifications.
- Procedural artifacts such as ischemic lesions must be distinguished from true pathogen-induced effects.
Biopharma FAQs
Why does null hypothesis testing matter for strain virulence comparison?
Null hypothesis testing enables statistically valid differentiation between Clostridium perfringens strains by comparing histopathological and microbiological outputs across controlled loops. This ensures that observed differences are attributable to strain-specific effects rather than procedural variability, supporting robust target validation.
How does independent variable isolation fit the ligated loop workflow?
By assigning each intestinal loop to a specific strain or control, the model isolates the independent variable—bacterial strain—within a single host. This design minimizes confounding factors and allows direct, within-subject comparison of pathogenicity.
What do quantitative dependent variable measurements enable in this model?
Quantitative measurements such as histopathological scoring and bacterial recovery provide objective endpoints for comparing strain virulence. These outputs support statistical analysis and enable reproducible, data-driven advancement decisions in discovery pipelines.
Why are replication requirements critical for cross-functional collaboration?
Replication across multiple loops and animals ensures that findings are robust and reproducible, facilitating data sharing and interpretation among discovery, pathology, and translational teams. This underpins cross-functional confidence in mechanistic conclusions and portfolio decisions.
What statistical analysis capabilities are required before implementing the loop model?
Teams must be equipped to perform statistical comparisons of quantitative outputs, such as lesion scores and bacterial counts, across experimental groups. This ensures that results are interpretable, actionable, and meet enterprise standards for discovery-stage rigor.
Chapters in this video
0:04
Title
0:56
Preparations
1:42
Extraction of the Small Intestines from the Abdominal Cavity
3:11
Fabricating Intestinal Loops and Injecting them with Pathogens
4:58
Completing the Procedure and Collecting Results
6:44
Results: Identifying Tissue Damage Caused by Pathogens or by Vascular Congestion
8:02
Conclusion
